ImageneBio (IMA) EBITDA (2020 - 2024)
Historic EBITDA for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to -$28.1 million.
- ImageneBio's EBITDA fell 2833.21% to -$28.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$64.2 million, marking a year-over-year increase of 1487.22%. This contributed to the annual value of -$49.1 million for FY2024, which is 2717.97% up from last year.
- ImageneBio's EBITDA amounted to -$28.1 million in Q4 2024, which was down 2833.21% from -$2.0 million recorded in Q3 2024.
- In the past 5 years, ImageneBio's EBITDA registered a high of $2.8 million during Q4 2021, and its lowest value of -$28.1 million during Q4 2024.
- Moreover, its 5-year median value for EBITDA was -$15.7 million (2023), whereas its average is -$14.5 million.
- As far as peak fluctuations go, ImageneBio's EBITDA skyrocketed by 11071.66% in 2021, and later crashed by 64133.24% in 2022.
- ImageneBio's EBITDA (Quarter) stood at -$26.1 million in 2020, then surged by 110.72% to $2.8 million in 2021, then crashed by 641.33% to -$15.1 million in 2022, then crashed by 44.95% to -$21.9 million in 2023, then fell by 28.33% to -$28.1 million in 2024.
- Its EBITDA stands at -$28.1 million for Q4 2024, versus -$2.0 million for Q3 2024 and -$15.8 million for Q2 2024.